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Both intracranial pressure (ICP) and the cerebrovascular pressure reactivity represent the
dysregulation of pathways directly involved in traumatic brain injury (TBI) pathogenesis and
have been used to inform clinical management. However, how these parameters evolve
over time following injury and whether this evolution has any prognostic importance have
not been studied.
Methods and findings
We analysed the temporal profile of ICP and pressure reactivity index (PRx), examined their
relation to TBI-specific mortality, and determined if the prognostic relevance of these param-
eters was affected by their temporal profile using mixed models for repeated measures of
ICP and PRx for the first 240 hours from the time of injury. A total of 601 adults with TBI,
admitted between September 2002 to January 2016, and with high-resolution continuous
monitoring from a single centre, were studied. At 6 months postinjury, 133 (19%) patients
had a fatal outcome; of those, 88 (78%) died from nonsurvivable TBI or brain death. The dif-
ference in mean ICP between those with a fatal outcome and functional survivors was only
significant for the first 168 hours after injury (all p < 0.05). For PRx, those patients with a
fatal outcome also had a higher (more impaired) PRx throughout the first 120 hours after
injury (all p < 0.05). The separation of ICP and PRx was greatest in the first 72 hours after
injury. Mixed models demonstrated that the explanatory power of the PRx decreases over
time; therefore, the prognostic weight assigned to PRx should similarly decrease. However,
the ability of ICP to predict a fatal outcome remained relatively stable over time. As control of
ICP is the central purpose of TBI management, it is likely that some of the information that is
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reflected in the natural history of ICP changes is no longer apparent because of therapeutic
intervention.
Conclusions
We demonstrated the temporal evolution of ICP and PRx and their relationship with fatal
outcome, indicating a potential early prognostic and therapeutic window. The combination
of dynamic monitoring variables and their time profile improved prediction of outcome.
Therefore, time-driven dynamic modelling of outcome in patients with severe TBI may allow
for more accurate and clinically useful prediction models. Further research is needed to con-
firm and expand on these findings.
Author summary
Why was this study done?
• Following a head injury, one of the most damaging aspects of brain trauma is an ele-
vated pressure inside the skull due to brain swelling.
• Knowledge of the relationship between the pressure inside the skull and time following
an injury could assist in capturing and potentially treating the most critical episodes and
could also identify the patients who might be at risk of poor outcome.
What did the researchers do and find?
• We investigated the relation of the pressure inside the skull and the brain’s ability to reg-
ulate its blood flow with time over the first 10 days following injury.
• Data from the first 3 days following injury seem to be able to predict death better than
data from the other days.
What do these findings mean?
• There might be a potential early window to treat patients and predict who was fatally
injured following their head injury.
• When developing models to predict death following brain trauma, it seems to be impor-
tant to take into account when the brain physiology data was captured.
Introduction
Traumatic brain injury (TBI) is a major worldwide cause of morbidity and mortality [1]; in
Europe alone, some 7.7 million people are living with TBI-induced disabilities [2], and of
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those with severe TBI (sTBI), a quarter to a third will die [3]. Furthermore, rates of severe mor-
bidity and mortality have not improved over the last 20 years [1,3]. This burden of disability
and mortality highlights the urgent need for novel strategies to decrease the prevalence and
improve the management of TBI [4].
Because the injured brain is vulnerable to metabolic, haemodynamic, and pressure-induced
insults [5–8], the overarching principle of the acute phase management focusses on the early
detection, prevention, and effective treatment of these secondary injuries [9]. Intracranial
hypertension and deranged cerebral haemodynamic regulation are key secondary injury
mechanisms and have been the subject of intensive research since the introduction of clinical
intracranial pressure (ICP) monitoring in the second half of the 20th century [10,11]. While
ICP monitoring remains a key element of therapeutic strategies and an objective standard for
measuring and monitoring sTBI patients, recent evidence has called into question how we
should be using, interpreting, or acting on ICP [12,13]. Additionally, the recently published
Randomized Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intra-
cranial Pressure (RESCUEicp) trial found that although the ICP-lowering strategy of decom-
pressive craniectomy (DC) decreases mortality, it also increases the likelihood of the patient
living with serious functional impairments [14].
Monitoring of cerebral haemodynamic regulation has also been used as a method for iden-
tifying vulnerable patients and informing patient management. Although early methods of
cerebral vascular regulation required cerebral blood flow (CBF) measurements before and
after a vasopressor challenge to give a snapshot of cerebrovascular function [15,16], modern
methods such as the pressure reactivity index (PRx) assess cerebral haemodynamic regulation
from spontaneous fluctuations of arterial blood pressure (ABP) and ICP and allow continuous
cerebrovascular pressure reactivity monitoring [17,18]. Cerebrovascular reactivity reflects pro-
cesses that maintain CBF at metabolically appropriate levels, and PRx has been associated with
patient outcome in several studies [19–21]. In addition, PRx has been proposed as a potential
guide for cerebral perfusion pressure (CPP) management [22,23]. To our knowledge, no study
has shown that monitoring of the cerebral pressure reactivity index has any effect on outcome.
Taking together recent evidence concerning ICP and the paucity of clinical effectiveness
data concerning PRx monitoring, we must first understand the temporal patterns, clinical
sequelae, and relevance of secondary injuries before we can successfully integrate neuromoni-
toring into personalised patient management. In particular, the natural history of both ICP
and PRx following sTBI is not well characterised; while some studies have investigated how
ICP changes over the monitoring period [24–28], these studies have not taken into account
the crucial reference time point—the precise time of acquiring the injury. Accurate elucidation
of temporal patterns in ICP and PRx is essential from both clinical and research perspectives.
Clinically, knowledge of temporal patterns in neuromonitoring data could assist in the deci-
sion process of how long to record ICP in order to capture and potentially treat the most criti-
cal episodes and also to allow early identification of patients with a severe injury who might be
at risk of death or persisting neurologic disability or require neuroprotective therapies or early
surgery. From a research perspective, temporal patterns of neuromonitoring data may be use-
ful for studying the response to new interventions, studying biomarkers associated with ICP or
PRx disturbance, or developing prognostic models.
In this prospectively collected neuromonitoring cohort in sTBI patients, we retrospectively
analysed the temporal profile of ICP and PRx, examined their relation to TBI-specific mortal-
ity, and determined if the prognostic relevance of these parameters was affected by their tem-
poral profile. On the basis of these analyses, we assessed a time-driven dynamic outcome
prediction model based on continuously monitored ICP and PRx.
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Methods
Study population
Data collection was approved by the relevant research ethics committee (30 REC 97/291) and
also includes routine clinical data not collected under patient/next-of-kin consent/assent that
was anonymized in accordance with United Kingdom legislation. As part of a prospective
observational neuro-monitoring cohort study, we included adults (16 years) who had sus-
tained a TBI and required management with ventilation and ICP monitoring at the Neuro
Critical Care Unit (NCCU) at Addenbrooke’s Hospital–Cambridge University Hospital NHS
Foundation Trust. Patients were admitted during a period from 1 September 2002 to 31 Janu-
ary 2016 and were managed according to TBI guidelines as part of tiered therapeutic protocols
that aim to control raised ICP and ensure adequate CPP. The management of patients with
severe TBI at the neurocritical care unit at Addenbrooke’s Hospital is based on the principles
outlined in 1999 [9]. ICP/CPP management protocols are not static but are updated on the
basis of available evidence/expert consensus. Three versions of the study protocol encom-
passed the 13-year observation period for this study. The differences between these protocols
can be summarized as follows: the upper CPP target was changed from 70 to 60 mm Hg in
2003 on the basis of the paper by Robertson et al. [29], and the lower limit of the end tidal CO2
target was changed from 4 kPa to 4.5 kPa on the basis of Coles et al. [30]. In the latest version
of the protocol (after the enrolment of the last patient in this study), the ICP target was relaxed
to 25 mm Hg. The latest version of our institutional ICP/CPP management protocol is publicly
available: http://cambridgecriticalcare.net/nccu-tbi-protocol/ (the management protocol has
been attached in S1 Supporting Information).
The computerised data storage protocol was reviewed and approved by the local ethics
committee of Addenbrooke’s Hospital, Cambridge University, and the NCCU User’s Group.
The study results are reported in accordance with the Transparent Reporting of a multivariable
prediction model for Individual Prognosis Or Diagnosis (TRIPOD) statement (S1 Appendix)
[31].
Data elements and outcome measures
Clinical data were abstracted and cross-validated from the emergency medical service reports,
hospital records, surgical reports, and medical imaging using standardised definitions derived
by group consensus prior to collection of the data. Demographics and other baseline character-
istics including date and time of injury and best preintubation score on the Glasgow Coma
Scale (GCS) were determined from the emergency medical service reports and the patient neu-
rocritical care admission assessment. Primary injury classification (diffuse injury or mass
lesion) was determined on the basis of the Marshall classification of the initial CT image of the
head. If the initial CT image of the head was not available, the classification was done on the
basis of the of the next available CT image of the head. Surgical interventions were further
classified as to whether a craniotomy for a mass lesion or a primary or secondary DC had
occurred. Primary DC was defined as a DC early in the management, with the patient under-
going emergent surgery (for example, for EDH or SDH evacuation) and the bone flap left out
following the initial surgery. Secondary DC was defined as an adjunct for persistent intracra-
nial hypertension when other ICP measures fail.
Patient outcome
Since non-neurologic organ dysfunction can significantly impact mortality following sTBI, it
is important to distinguish between fatality due to neurological causes (nonsurvivable TBI or
Temporal profile of ICP and PRx in severe TBI
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002353 July 25, 2017 4 / 21
brain death) and fatality due to a non-neurologic cause [32–34]. The cause of death and con-
tributing factors to mortality were determined by review of hospital records or by the acquisi-
tion of a death certificate or autopsy reports.
In order to assess the prognostic and predictive ability of brain physiological parameters for
mortality, the main outcome measure for the current study was mortality at 6 months postin-
jury due to a neurological cause. The latter group was compared to functional survivors; this
has been defined as survivors with severe or moderate disability or good recovery. The time
course of ICP and PRx was also further stratified by functional status at 6 months postinjury
using the Glasgow Outcome Scale (GOS) to evaluate if this TBI cohort generally reflects the
same functional outcome distribution commonly reported in severe TBI cohorts and if our
results could be generalised. GOS was determined by clinical research nurses in 3 ways: (1)
through the hospital record, if the patient died in-hospital; (2) during a hospital visit to the
neurotrauma or neurorehabilitation clinic 6 months after admission; or (3) by phone inter-
view, either of the patient himself/herself or his/her relatives [35].
Data acquisition and analyses
ICP was monitored with an intraparenchymal microsensor inserted into the frontal lobe (Cod-
man ICP MicroSensor, Codman & Shurtleff, Raynham, Massachusetts), and ABP was moni-
tored in the radial or femoral artery with a 0 calibration at the level of the right atrium (Baxter
Healthcare, California, United States; Sidcup, UK). Data were sampled at a minimum of 100
Hz with proprietary data acquisition software (ICM+, Cambridge Enterprise, Cambridge, UK,
http://www.neurosurg.cam.ac.uk/icmplus) and stored for subsequent analysis.
PRx was calculated as the Pearson correlation of 30 consecutive 10-second average values of
ABP and ICP. A 10-second average was used to reduce the influence of respiratory and pulse
waveforms. A 300-second moving window, updated every 1 minute, was used to generate con-
tinuous PRx values.
Mean values of physiologic variables were calculated in 24-hour epochs referenced from
the time of injury (T0) to 240 hours postinjury (T240). All mean ICP or PRx values for every
24-hour epoch of every study participant were only calculated if 50% or more of the epoch’s
recording was available. Recording data of all patients were reviewed for artefacts, and if pres-
ent, those minutes were excluded.
Because of the latency between the time of injury and the start of the recording (e.g., due to
interhospital transfers, delayed ICP transducer insertion, and/or delay in connecting to data
acquisition software), very early time points are frequently missing. Other reasons why gaps
could occur in the recordings are as follows: the patient required a shorter period of monitor-
ing than 240 hours postinjury (i.e., ICP within normal ranges or withdrawal of treatment), the
patient did not require monitoring initially (i.e., patient deteriorated and required monitoring
subsequently), the patient had less than 50% of the 24-hour epoch’s recording available, or the
patient was monitored but the data was not recorded. The latter arises because patients can be
often temporarily disconnected at different times of the day (e.g., washing and wheeling to
imaging studies). In these cases, a member of the study team was required to manually recon-
nect and resume the recording.
Statistical analysis
The analysis plan for this study was developed as part of a doctorate thesis investigating tempo-
ral profiles of brain physiological parameters following severe TBI and was determined before-
hand, during the designing stages of the study. The analysis did not differ from the original
plan; however, following the suggestion of reviewers, we performed one additional analysis
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(analysis plan attached as S2 Appendix). Descriptive statistics were used to summarise the
study population. Data for continuous variables are presented as means with standard devia-
tions (SDs) or medians with interquartile ranges (IQRs). Categorical data are presented as
counts and frequencies. Continuous variables were compared between survivors and nonsur-
vivors using a t test or Wilcoxon Rank Sum test, depending on the normality of the data. Cate-
gorical data were compared using a Pearson’s chi-square test or Fisher’s exact test. The raw
means of ICP and PRx from T24 to T240 were plotted, and the difference between strata was cal-
culated using an ANOVA test with Bonferroni post hoc adjustments.
Three complementary statistical approaches were employed to evaluate the impact of the
temporal profile of ICP and PRx on fatal outcome. First, to assess the difference in brain physi-
ological parameters and their trajectories between those with a fatal outcome and functional
survivors, we utilized a linear mixed-effects model (LMEM) with a between-subjects factor
(group: fatal versus nonfatal), a within-subject factor (time: T24 to T240), and the interaction
between these 2 with patient ID as a random effect. An unstructured covariance structure pro-
vided the best model fit based on the Akaike Information Criterion. The following variables
were used for adjusting the model: age, sex, best preintubation GCS, primary injury type (dif-
fuse versus mass lesion), and surgical interventions (none, craniotomy, primary DC, and sec-
ondary DC). Since DC is a strong modulator of ICP and the “open skull model” may affect the
reliability of the cerebrovascular reactivity assessment, an adaptive intervention parameter was
used for the DC variable whereby the occurrence of the intervention over time was adjusted to
the exact time point (T24 to T240) when the procedure took place. In addition to plotting the
raw means of ICP and PRx over time, Bonferroni adjusted pairwise multiple comparisons of
the estimated marginal means (EMMs) were generated with LMEMs. These means are calcu-
lated for the 2 outcome groups for each 24-hour epoch by taking into account all fixed and
random effects variables used in the LMEM.
Second, a generalized linear mixed model (GLMM) was next used to examine the effect of
ICP and PRx on the probability (odds ratio [OR]) of having a fatal outcome over time, using
repeated measures of these parameters over the first 240 hours postinjury. The model also
included the same fixed and random effects and interactions term as the LMEM model.
The third approach tested how well ICP and PRx could distinguish between fatal outcome
and functional survivors during different time points (T24–T240); the area under the receiver
operating characteristic curve (AUC-ROC) was calculated and compared. ROC curves are fre-
quently used for displaying sensitivity and specificity of a continuous diagnostic marker (i.e.,
ICP or PRx) for a binary disease variable (fatal outcome yes/no). However, many disease
markers and outcomes are time dependent, and ROC curves that vary as a function of time
may be more appropriate. Therefore, we summarised the discrimination potential of ICP and
PRx by calculating ROC curves for the cumulative effects of ICP and PRx by time (T24–T240)
using GLMMs.
All statistical analyses were conducted using R statistical software version 3.2.3 [36] and




A total of 601 severe TBI patients with high-resolution continuous monitoring were identified
over the study period, with a cumulative sum of 92,737 hours of monitoring data following
artefact clearing. The median (IQR) total time of monitoring for all patients was 126 (156)
hours. Excluded 24-hour epochs (because of recordings covering < 50% of the 24-hour
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period) were further evaluated, and this evaluation demonstrated that most excluded epochs
were in the first 24 hours, with a median recording duration of 4 hours (Table A–F in S2 Sup-
porting Information). The mean (SD) age was 39 (17) years, 77% were males, and 70% of
patients sustained diffuse brain injury (Table 1). The best preintubation GCS for the majority
Table 1. Baseline characteristics of 601 severe traumatic brain injury (sTBI) patients with high-resolu-
tion continuous monitoring, diagnosed between September 2002 and January 2016.
n %









Mass lesion 178 30
Surgical interventions
No interventions 356 60
Craniotomy for mass lesion 73 12
Extradural 23 (32)
Acute subdural 38 (52)
ICH/contusion 12 (16)
Primary DC for mass lesion 86 14
Extradural 12 (14)
Acute subdural 63 (73)
ICH/contusion 11 (13)
Secondary DC for refractory ICP 86 14
DC type
Bifrontal craniectomy 44 26
Hemicraniectomy 126 73
Posterior fossa decompression 2 1
Mean time from injury to primary DC (median hours [IQR]) 6.0 [5.0]
Mean time from injury to secondary DC (median hours [IQR]) 45 [81]
Glasgow Outcome Scale at 6 months
Death 113 19
Vegetative state 20 3
Severe disability 203 34
Moderate disability 152 25
Good recovery 113 19
Causes of death
Non-neurological cause 25 22
Nonsurvivable TBI or brain death 88 78
Days from injury to death (median [IQR]) 12 [13]
Monitoring time in hours (median [IQR]) 126 [156]
Abbreviations: DC, decompressive craniectomy; GCS, Glasgow Coma Scale; ICH, intracerebral hematoma;
ICP, intracranial pressure; IQR, interquartile range; TBI, traumatic brain injury; SD, standard deviation.
Values within parentheses represent subtable percentages.
https://doi.org/10.1371/journal.pmed.1002353.t001
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of patients was between 3 and 8. Forty percent of patients underwent a trauma craniotomy or
craniectomy during their admission. Acute subdural haematomas (aSDHs) were the most
frequently evacuated mass lesion in this cohort. Of those who underwent a DC, 50% of the
patients underwent a primary DC for evacuation of a mass lesion, and the other 50% a second-
ary DC for refractory raised ICP. Almost all primary DCs were performed within the first day
following injury, while on average secondary DCs were performed on the fourth day following
injury (Table 1). A total of 113 patients (19%) had a fatal outcome within the study period, and
the median (IQR) time from injury to death was 12 (13) days. The overall functional outcome
according to the GOS is presented in Table 1. Almost one-fourth of the patients in this cohort
with a fatal outcome died from non-neurological causes (i.e., respiratory failure, sepsis, or
myocardial infarction). The baseline characteristics of those with a fatal outcome (due to non-
survivable TBI or brain death) or functional survivors (severe disability, moderate disability,
and good recovery) at 6 months postinjury were further stratified in Table 2. Patients with a
fatal outcome due to neurological causes were older (45 ±18 years versus 38 ± 16 years, p<
0.001), had a lower preintubation GCS (81% versus 70% GCS of 3–8, p = 0.047), required
more surgical interventions (56% versus 38%, p< 0.001), had a higher mean ICP (21.0 ± 10.2
mmHg versus 15.1 ± 8.2 mmHg, p< 0.001), a lower mean CPP (75.9 ± 8.3 mmHg versus
78.5 ± 8.0 mmHg, p = 0.009), a higher mean PRx (0.16 ± 0.21 a.u. versus 0.05 ± 0.15 a.u., p<
0.001), and spent more time in pathological ranges of ICP (>25 mmHg) (18.0% [32.7%] versus
2.60% [6.90%] of total monitoring time, p< 0.001) and PRx (>0.25) (42.9% [32.9%] versus
32.2% [19.6%] of total monitoring time, p< 0.001). No differences were observed in sex, pri-
mary injury type, or DC type. Also, the median monitoring time for fatal and nonfatal (p =
0.991) and the median time to primary and secondary DC (p = 0.893 and p = 0.558, respec-
tively) did not differ between the 2 outcome groups.
The course of ICP and PRx over time
Heat maps showing the ICP and PRx parameters from 601 sTBI patients over the course of the
first 240 hours postinjury are shown in Fig 1. The heat map showed that the high levels of ICP
were associated with fatal outcome from neurological causes. In contrast, a fatal outcome due
to non-neurological causes did not demonstrate raised ICP during the first 240 hours, except
for the first 24-hour epoch. However, there were only 2 patients contributing data to this first
time point. Levels of PRx in fatal outcome demonstrated that the 2 different causes of death
showed differential patterns of cerebrovascular impairment. In the group experiencing fatal
outcome from neurological causes, cerebrovascular pressure reactivity seemed to be impaired
in the first 72 hours following the injury. However, patients with a fatal outcome from non-
neurological causes demonstrated late impairment in pressure reactivity after 168 hours fol-
lowing injury, possibly due to the development of (multiple) organ dysfunction. No distinct
patterns of ICP were observed to discriminate between different levels of functional outcome
(severe disability–good recovery). The PRx heat map, however, did show a pattern of lower
values of PRx with higher levels of functional outcome (severe disability compared to moderate
disability or good recovery). Patients in a vegetative state did not demonstrate patterns differ-
ent from other survivors; however, given the limited number of patients in this group and at
each 24-hour time point, the interpretation of these patterns has to be done cautiously. Physio-
logically “abnormal” thresholds of ICP (>25 mm Hg) and PRx (>0.25 a.u.) were visualised in
Fig 1C and 1D and were based on the recent RESCUEicp trial, which used a threshold of 25
mm Hg for intracranial hypertension, and studies that found a PRx of>0.25 gave the best sta-
tistical separation between outcomes [14,19].
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Observed and estimated means by outcome
As expected, in the immediate postinjury period the number of patients in the first 24 hours
postinjury is limited (Fig 2A and 2B). In terms of patients experiencing a fatal outcome, it is
unlikely that a disproportionate number of patients expiring in the early time points (Fig 2A
and 2B) is giving a false impression of time course: the number of patients with a fatal outcome
contributing to each 24-hour epoch remained relatively stable over the first 10 days following
injury. There is no peak incidence of death at any time point, and the number of deaths
remains proportional to the nonfatal group (Fig 2A and 2B). Mean ICP was on average higher
than 20 mmHg 48 hours after injury only in those with a fatal outcome (Fig 2A). The differ-
ence in mean (95% CI) ICP between those with a fatal outcome and functional survivors was
Table 2. Baseline characteristics of 556 severe traumatic brain injury (sTBI) patients stratified by fatal outcome (due to nonsurvivable TBI or brain
death) and functional survivors (ranging from severe disability to good recovery) at 6 months postinjury.
Functional survivors (n = 468) Fatal outcome (n = 88)
N (%) N (%) p-value†
Age in years (mean ± SD) 38 ± 16 45 ± 18 <0.001*
Sex 0.943
Female 108 (23) 20 (23)
Male 360 (77) 68 (77)
Best preintubation GCS 0.047*
3–8 329 (70) 71 (81)
9–15 139 (30) 17 (19)
Primary injury type 0.247
Diffuse 337 (72) 58 (66)
Mass lesion 131 (28) 30 (34)
Surgical interventions <0.001*
No interventions 293 (62) 39 (44)
Craniotomy for mass lesion 55 (12) 10 (12)
Primary DC for mass lesion 56 (12) 23 (26)
Secondary DC for refractory ICP 64 (14) 16 (18)
DC type 0.465
Bifrontal craniectomy 34 (28) 8 (20)
Hemicraniectomy 85 (71) 30 (77)
Posterior fossa decompression 1 (1) 1 (3)
Hours from injury to primary DC (median [IQR]) 6.4 [6.4] 7.9 [6.3] 0.893
Hours from injury to secondary DC (median [IQR]) 55 [96] 73 [137] 0.558
Monitoring time in hours (median [IQR]) 124 [161] 146 [150] 0.991
ICP mmHg (mean ± SD) 15.1 ± 8.2 21.0 ± 10.2 <0.001*
CPP mmHg (mean ± SD) 78.5 ± 8.0 75.9 ± 8.3 0.009*
PRx a.u. (mean ± SD) 0.05 ± 0.15 0.16 ± 0.21 <0.001*
% of monitoring ICP > 25 mmHg (median [IQR]) 2.60 [6.90] 18.0 [32.7] <0.001*
% of monitoring PRx > 0.25 a.u. (median [IQR]) 32.2 [19.6] 42.9 [32.9] <0.001*
† p-values were calculated by X2-test for sex, GCS, injury, and DC type, and surgical intervention; by the Mann-Whitney U-test for time to DC, monitoring
time, and % time > thresholds; and by a Student’s t test for age, ICP, CPP, and PRx.
*Statistically significant p < 0.05.
Abbreviations: 95% CI, 95% confidence interval; CPP, cerebral perfusion pressure; DC, decompressive craniectomy; GLMM, generalized linear mixed
model; GCS, Glasgow Coma Scale; ICH, intracerebral hematoma; ICP, intracranial pressure; OR, odds ratio; PRx, pressure reactivity index; SD, standard
deviation; TBI, traumatic brain injury.
https://doi.org/10.1371/journal.pmed.1002353.t002
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only significant for the first 168 hours after injury (Fig 2A: T48 16.1 [15.3–17.0] versus 20.6
[18.1–23.2], T72 15.7 [14.9–16.5] versus 19.4 [17.9–21.0], T96 14.9 [14.2–15.6] versus 19.6
[17.6–21.6], T120 15.2 [14.3–16.1] versus 18.2 [16.1–20.3], T144 15.7 [14.6–16.8] versus 18.9
[16.8–21.0], T168 16.4 [15.2–17.5] versus 19.0 [15.9–22.2], all p< 0.05). While the time course
of the mean ICP was relatively flat, 2 minor peaks in ICP can be appreciated from 48–72 hours
and at 216 hours (Fig 2A and 2C). Mean (95% CI) values of PRx demonstrated significantly
higher (impaired) levels in those with a fatal outcome during the first 120 hours postinjury
(Fig 2B: T24 0.05 [−0.01 to 0.11] versus 0.36 [0.18–0.55], T48 0.01 [−0.02 to 0.04] versus 0.24
[0.17–0.31], T72 −0.01 [−0.03 to 0.02] versus 0.16 [0.07–0.25], T96 −0.02 [−0.04 to 0.00] versus
0.09 [0.01–0.17], T120 0.00 [−0.02 to 0.02] versus 0.09 [0.02–0.16], all p< 0.05), with abnor-
mally high values observed mainly in the first 48 hours postinjury.
The estimated means from the LMEM showed the difference in the trajectory of fatal out-
come patients and functional survivors across the first 240 hours postinjury after adjusting for
patient, injury, and treatment characteristics. The estimated means of ICP demonstrated that
Fig 1. Heatmap illustrating levels of intracranial pressure (ICP) and pressure reactivity index (PRx) in 601
severe traumatic brain injury (TBI) patients stratified by different levels of functional outcome. The colour
code represents (A) mean ICP, (B) mean PRx, (C) percent time spent ICP > 25 mmHg, and (D) percent time spent
PRx > 0.25 for each 24-hour epoch following injury. Tabulated heatmaps are available as supporting information
(Table A–D in S3 Supporting Information). Abbreviations: NC, neurological cause.
https://doi.org/10.1371/journal.pmed.1002353.g001
Temporal profile of ICP and PRx in severe TBI
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002353 July 25, 2017 10 / 21
ICP levels were significantly different at all time points between the 2 outcome groups, except
for the first 24 hours (Fig 2C). Patients with a fatal outcome had ICP values above 20 mmHg
for all time points after the first 24 hours. Functional survivors showed low levels of ICP
throughout the first 240 hours, with a relatively steady decrease over time. The estimated
means of PRx demonstrated only significant differences between the patients with fatal out-
comes and those with nonfatal outcomes during the first 96 hours following injury (Fig 2D).
While the trajectories of the estimated means of PRx are relatively similar to the observed
means, a smaller separation of PRx values between the fatal and nonfatal groups can be noted.
Generalized linear mixed model
In addition to the dynamic variables (ICP, PRx, CPP, and surgical interventions), patients’
baseline and injury characteristics were considered as potential prognostic variables and were
included in the GLMM (Table 3). The results of this analysis identified age at injury (OR 1.05
[95% CI 1.02–1.07, p< 0.001]); best preintubation GCS: a higher GCS score demonstrated a
lower likelihood of a fatal outcome (OR 0.60 [95% CI 0.45–0.80, p< 0.001]); and primary
injury type with mass lesions demonstrating a lower likelihood of a fatal outcome when com-
pared to diffuse injuries (OR 0.20 [95% CI 0.12–0.34, p< 0.001]); the results also revealed that
patients requiring surgical interventions demonstrated a higher likelihood of fatal outcome,
with craniotomy for mass lesions (OR 6.43 [95% CI 3.56–11.60]), primary DC for mass lesion
(OR 13.19 [95% CI 7.60–22.89]), and secondary DC for refractory ICP (OR 1.48 [95% CI
1.05–2.07]) (all p 0.05), ICP (OR 1.19 [95% CI 1.12–1.25, p< 0.001]), and PRx (OR 11.43
Fig 2. Observed mean values of (A) intracranial pressure (ICP) and (B) pressure reactivity index (PRx) of 556 traumatic brain injury (TBI) patients
stratified by functional survivors and fatal outcome due to neurological causes for each 24-hour epoch for the first 240 hours after injury. The
estimated marginal means (EMMs) of (C) ICP and (D) PRx are plotted over the same strata as derived from the repeated-measures generalized
linear mixed model (GLMM) after adjusting for patient, injury, and treatment characteristics.
https://doi.org/10.1371/journal.pmed.1002353.g002
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[95% CI 2.84–45.92, p = 0.001]) shown as being associated with fatal outcome (Table 3). Sex
and CPP were not significantly associated with outcome.
Evolution of AUC-ROC
The predictive ability of 3 different models to distinguish death from neurological causes ver-
sus survival is shown in Fig 3. Model 1 uses a GLMM to predict fatal outcome using only the
traditional static (or constant) clinical predictive variables such as age, sex, preintubation GCS,
primary injury type, and surgical interventions. This model was relatively constant (with an
AUC-ROC of approximately 0.69) throughout the first 10 days postinjury owing to the fact
that most of these variables remain constant over time, and only small variations will be con-
tributed by the addition of patients as time increases and more patients are added to the
model. Model 2 utilised the same GLMM from Model 1 but combined the constant prognostic
factors with the cumulative addition of the dynamic monitoring variable, ICP. The addition of
ICP to the model significantly improved the ability to distinguish death due to neurological
causes from survival. Although the AUC-ROC for the ICP model was highest from day 0 to
day 2 (AUC-ROC = 0.80; 95% CI 0.74–0.87), the AUC-ROC was not significantly lower with
the accumulation of ICP data from 0–240 hours, as indicated by overlapping AUC-ROC values
and their confidence intervals (all p> 0.05). The third model incorporated the constant
Table 3. A generalized linear mixed model (GLMM) was used to test for associations between the
independent variables and fatal outcome by taking into account repeated measures and their interac-
tions with time.
GLMM analysis
OR (95% CI) p-value†




Best preintubation GCS <0.001*
3–8 Ref
9–15 0.60 (0.45–0.80)
Primary injury type <0.001*
Diffuse Ref
Mass lesion 0.20 (0.12–0.34)
Surgical interventions 0.006*
No interventions REF
Craniotomy for mass lesion 6.43 (3.56–11.60)
Primary DC for mass lesion 13.19 (7.60–22.89)
Secondary DC for refractory ICP 1.48 (1.05–2.07)
ICP mmHg 1.19 (1.12–1.25) <0.001*
CPP mmHg 0.98 (0.93–1.05) 0.594
PRx a.u. 11.43 (2.84–45.92) 0.001*
† p-values were calculated using a GLMM.
*Statistically significant p < 0.05.
Abbreviations: 95% CI, 95% confidence interval; CPP, cerebral perfusion pressure; DC, decompressive
craniectomy; GCS, Glasgow Coma Scale; GLMM, generalized linear mixed model; ICH, intracerebral
hematoma; ICP, intracranial pressure; OR, odds ratio; PRx, pressure reactivity index; Ref, reference group;
SD, standard deviation; TBI, traumatic brain injury.
https://doi.org/10.1371/journal.pmed.1002353.t003
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prognostic factors (GLMM Model 1) with the cumulative addition of the dynamic monitoring
variable PRx and demonstrated a superior predictive ability (AUC-ROC = 0.86; 95% CI 0.81–
0.92) using data from the first 48 hours postinjury when compared to the first 120 to 240 hours
(AUC-ROC = 0.77; 95% CI 0.73–0.80, to AUC-ROC = 0.74; 95% CI 0.72–0.77 [all p< 0.05]).
Discussion
In a cohort study of 601 patients with sTBI, we demonstrate that despite relatively stable ICP
throughout the first 10 days postinjury, cerebral pressure reactivity is impaired early after
injury. Furthermore, studying the prognostic importance of brain physiological parameters
after separating neurological from non-neurological causes of death resulted in a strong rela-
tionship of both ICP and pressure reactivity with fatal outcome from neurological causes,
which is clinically meaningful and arguably more relevant. Finally, the inclusion of ICP and
pressure reactivity into a dynamic predictive model demonstrated the importance of the tem-
poral profile of these parameters; inclusion of ICP or pressure reactivity significantly improved
our ability to predict patient outcome when compared to static variables. Currently, the most
commonly used TBI prediction models only utilise fixed variables [37,38].
Fig 3. Time-dependent receiver operating characteristic (ROC) curve analysis for prediction of fatal
outcome due to neurological causes. The evolution of the area under the ROC curve (AUC-ROC) of 3
different models over time has been plotted. Generalized linear mixed model (GLMM) Model 1: static
(constant) variables with patient, injury, and treatment characteristics. GLMM Model 2: repeated measures of
intracranial pressure (ICP) including static variables from Model 1. GLMM Model 3: repeated measures of
pressure reactivity index (PRx) including static variables from Model 1. At each time point, GLMM Models 2
and 3 are using repeated measures of the dynamic variables (ICP and PRx) from baseline to the respective
time point. Due to the limited sample size for T24, data have not calculated and plotted for this time point
separately. The tabulated graph is available as supporting information (Table A in S4 Supporting Information).
https://doi.org/10.1371/journal.pmed.1002353.g003
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ICP and PRx evolution
While many studies document ICP monitoring data after TBI, the vast majority of these
neglect the time-varying nature of the signal. Published studies seem to agree that ICP
increases at some point after injury, but the timing remains elusive, with 1–3, 3–5 and 7–14
days all being proposed as time frames [9,10,13,14,20]. The causes of this increased ICP after
TBI could be evolving cerebral oedema, changes in cerebral blood volume, or the development
of mass lesions [39–41].
In the current study, we found an increased ICP in those with death from neurological
causes in both the raw ICP and adjusted ICP profile (Figs 1 and 2), supporting the concept that
ICP is an important contributor to harmful secondary brain injuries. Of note, the increased
ICP in the nonsurvivors was apparent in most cases well before the patient death (ICP in-
creased on day 1, and the average time of patient death is 17 days) (Table 1). However, in the
current study we did not find a strong temporal evolution of ICP, despite the large sample size
and the accurate determination of the time of injury (Figs 1 and 2). Heterogeneity of TBI
pathophysiology could be contributing to this absence of a clear temporal profile. Further-
more, as clinical protocols have developed in which control of ICP is the central purpose of
sTBI management, it is likely that some of the information that is reflected in the natural his-
tory of ICP changes is no longer apparent because of therapeutic intervention. As such, a
raised ICP in this patient cohort represents a failure to control ICP with the medical and surgi-
cal means at the treating physician’s disposal. This lack of a clear time course is consistent with
the disparate timings of increased ICP reported in previous, smaller investigations and under-
scores the fact that predicting the timing of increased ICP based purely on time of monitoring
is problematic; increased ICP can occur at any time in the acute management phase and is uni-
formly deleterious.
Cerebral pressure reactivity was both impaired early (0–3 days) and showed a deteriorating
course later (5–10 days) after injury (Fig 2B and 2D); however, this first impairment was only
observed in the patients who subsequently died because of neurological causes. This early pres-
sure reactivity derangement possibly implicates vascular impairment stemming from the pri-
mary injury and could have relevant therapeutic and research implications; a therapy aiming
to optimise cerebrovascular function after TBI should focus on the first 3 days after injury, as
should novel biomarkers or noninvasive estimates of cerebrovascular impairment.
As the second (delayed) pattern of worsening pressure reactivity is present in both the sur-
vival and mortality outcome groups, it appears to have less clinical relevance and may not nec-
essarily be a sensitive marker of cerebral injury. Explanations of this temporal evolution are,
however, difficult; in contrast to the scant studies on the time course of ICP after injury, this is
the only study (to our knowledge) to assess continuous cerebral vascular reactivity in relation
to time from injury. In contrast to our findings, investigations intermittently assessing pres-
sure autoregulation using transcranial Doppler have found impaired pressure autoregulation
in the first 4–5 days postinjury before a gradual return towards normal values [42–45]. Cere-
brovascular reactivity can be seen as a proxy variable of various neuropathophysiological pro-
cesses and interventions that can modulate it. Secondary worsening in cerebral pressure
reactivity could also be influenced by treatments administered during the monitoring period,
including alterations in PaCO2 during ventilator weaning [43,46], changes in pharmacological
sedation [47], or temperature management [48]. Secondary worsening could also be a sequelae
pathophysiological processes, i.e., the development of post-traumatic vasospasm, which has
been shown to occur in approximately 40% of TBI patients and presents with a not dissimilar
time course [49]. Fig 3 demonstrated statistically better predictive ability of PRx in the first 48
hours postinjury when compared to the first 120 to 240 hours. Therefore, this finding may
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suggest that PRx impairment in the first 2 days is reflecting pathophysiological processes with
good discriminatory power for fatal outcome; however, from day 5 onwards, the pathophysio-
logical pathways that modulate PRx might not be the same ones from the first days and there-
fore might not be able to discriminate fatal outcome with the same power, leading to a
decreasing evolution of the AUC-ROC over time.
Neurological monitoring is related to neurological outcome
In the current study, patients who died because of neurological causes showed distinctly differ-
ent ICP and pressure reactivity time courses when compared to those who died because of
non-neurological causes (Fig 1). While traditionally studies relate monitored variables to all-
cause mortality or GOS, using such nonspecific outcome measures may obscure important
relationships. Acknowledging that the current study did not use a validated instrument to
assess neuronal specific injury, the relatively crude method of dichotomizing patients who
died into neurologic and non-neurologic causes nevertheless provided fruitful; almost a quar-
ter of the patients who died did so because of non-neurologic causes, and in these patients,
both ICP and pressure reactivity over the first 5 days were normal. This distinction may be
especially relevant in cases of multitrauma.
Interestingly, pressure reactivity 5–10 days after injury is markedly increased in those who
died due to non-neurological causes. This perhaps reflects the multivariate nature of vascular
dysregulation; indeed, previous investigations have shown disturbed cerebral vascular function
during seemingly non-neurological scenarios such as impaired arterial glucose regulation,
impaired kidney function, or after red blood cell transfusion [50–52]. In addition, common
conditions in this group included sepsis, respiratory failure, and postresuscitation from cardiac
arrest, all of which have been shown to be characterised by impaired cerebrovascular reactivity
and resulting in high short-term mortality [53–56].
ICP and PRx monitoring as a time-driven adaptive outcome prediction tool
ICP and PRx monitoring can facilitate reasonably accurate, personalised, and dynamic assess-
ments of patient prognosis. In our analysis, the explanatory power of the PRx decreases over
time; therefore, the prognostic weight assigned to PRx should similarly decrease (Fig 3). For
ICP, no significant changes were seen over time for its ability to predict fatal outcome. By
accumulating information regarding secondary injuries from intracranial hypertension or
cerebrovascular dysregulation, an adaptive model has the potential to inform therapy intensity,
assess treatment efficacy, and provide up-to-date prognostic information for clinical use.
Furthermore, because ICP and ABP are the cornerstones of monitoring after sTBI, the
inclusion of ICP and PRx into an adaptive model in most cases requires no additional inconve-
nience or harm to the patient. The inclusion of the monitoring data merely makes effective use
of data that might otherwise be discarded. While the current study focussed on ICP and PRx
monitoring data, it is conceivable that the addition of other neuromonitoring data that address
distinct pathophysiological processes may further improve the accuracy of the model. In this
regard, dynamic markers of intracranial compliance, autonomic nervous system activity, or
cerebral metabolism may be useful adjuncts [7,57,58]
Rather than aiming to replace existing prognostic models, such as the Corticosteroid Ran-
domisation after Significant Head Injury (CRASH) and International Mission for Prognosis
and Analysis of Clinical Trials in TBI (IMPACT-TBI) models, which have been shown to have
good discriminating ability [37,38], the purpose of this predictive model was to assess the
value of including knowledge about the patient’s state of current physiology. Such an adaptive
model may more closely align with clinical acumen and Bayesian inferencing, whereby
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estimation of outcome is informed by the prior information (from the constant predictive vari-
ables) and updated with new information from the monitored predictors.
Limitations
The current study has certain limitations. First, in the current cohort, measurement of ICP
and PRx over all 10 days was not possible for all patients: some patients required a short period
of monitoring (i.e., because of ICP within normal ranges), some did not require monitoring
initially (i.e., patient deteriorated and required monitoring later on), and in some, disconnec-
tions from the recording hardware occurred. This, however, reflects the clinical reality of neu-
romonitoring after sTBI. Also, measurements of pupil reactivity were not reliably obtainable
for all patients in this cohort, as prognostic models for sTBI derived from the CRASH and
IMPACT studies both support the use of pupil reactivity in building prognostic models for
patient outcome based on initial patient characteristics [37,38]. Since the study period spanned
over 13 years, changes in treatment protocols over the study period had to be tested by adding
a term for calendar time in our models, demonstrating no significant effect on our outcome
measures. The inevitable updating of the protocol is unlikely to influence the primary findings
of this study—i.e., that temporal profiles of ICP and PRx differ according to fatal outcome.
This is because across the entire study period, intracranial hypertension was vigorously treated
and did not vary depending on how many days the patient was postinjury.
The observed time courses of ICP and PRx could be due to the interventions received dur-
ing their NCCU stay and not the natural history of the disease. These parameters are modu-
lated by various treatments and in the case of ICP directly targeted (as part of tiered protocols)
to be maintained within certain limits. As PRx is not directly targeted using our current thera-
peutic strategies, this may explain why it provides additional prognostic information com-
pared to the target-driven control of ICP. We have adjusted our analyses for the injury type
and surgical treatments and particularly focused on DC by using a time-driven DC variable.
Since DC has been shown to lead to a dramatic reduction in ICP and influence CR, we have
adjusted all repeated measures of ICP and PRx in our LMEM and GLMM for the occurrence
of DC [59]. It would have been advantageous to adjust for the intensity of other intervention
parameters (hyperosmolar therapies, hyperventilation, and hypothermia); however, these data
were not available for our cohort.
Although this is the largest evaluation of the temporal profile of neuromonitoring variables
to date, it has been conducted at a single institution. Thus, the current findings describing tem-
poral evolution of neuromonitoring data and the adaptive prognostic model should be exter-
nally validated in a multicentre prospective study.
Finally, while the evolution of ICP and pressure reactivity has been described, the underly-
ing pathophysiology of these profiles remains occult. Building on this temporal approach, fur-
ther work should investigate treatment effects and their relationship with other aspects of
patient pathology and physiology. Both parameters carry potential to provide utility as predic-
tive parameters because they represent the dysregulation of pathways directly involved in
pathogenesis [60,61]. However, further studies are needed not only to characterise these
parameters as descriptive biomarkers (reflecting only the state/severity of the injury) and/or as
actionable biomarkers (to guide clinical management and measure treatment response) but
also to study how their temporal profile affects these characteristics.
Conclusions
In this large single-centre cohort study, we demonstrate the temporal evolution of ICP and
cerebral pressure reactivity index, indicating a potential early prognostic and therapeutic
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window. By distinguishing neurological from non-neurological causes of death, robust rela-
tionships of ICP and PRx and their time course with outcome were obtained. Finally, the com-
bination of static clinical prognostic factors and dynamic monitoring variables contributed to
a significantly better prediction of outcome. Therefore, time-driven dynamic modelling of out-
come in sTBI patients may allow for more accurate, temporally relevant, and clinically useful
prediction models.
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